 SUNNYVALE, Calif., Nov. 02, 2022 GLOBE NEWSWIRE -- BioCardia, Inc. NASDAQ:BCDA, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the three and nine months ended September 30, 2022 and provide a corporate update by conference call on Wednesday, November 9, 2022 at 4:30 PM ET. Following managements formal remarks, there will be a question-and-answer session. 